NCT02320981View on ClinicalTrials.gov

Mucosal Impedance in Pediatric Population

CompletedOBSERVATIONAL
Enrollment

127

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Gastroesophageal Reflux Disease (GERD)Eosinophilic Esophagitis (EoE)Functional Dyspepsia
Interventions
DIAGNOSTIC_TEST

Standard of Care esophagogastroduodenoscopy (EGD) with measurement of mucosal impedance

Trial Locations (1)

37232

Vanderbilt Children's Hospital, Nashville

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Vanderbilt University Medical Center

OTHER

NCT02320981 - Mucosal Impedance in Pediatric Population | Biotech Hunter | Biotech Hunter